tiprankstipranks
Alto Neuroscience, Inc. (ANRO)
NYSE:ANRO
US Market
ANRO
Alto Neuroscience, Inc.
RESEARCH TOOLSreports
Want to see ANRO full AI Analyst Report?

Alto Neuroscience, Inc. (ANRO) Stock Forecast & Price Target

570 Followers
See the Price Targets and Ratings of:

ANRO Analyst Ratings

Strong Buy
11Ratings
Strong Buy
10 Buy
1 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Alto
Neuroscience, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ANRO Stock 12 Month Forecast

Average Price Target

$35.22
▲(27.06% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Alto Neuroscience, Inc. in the last 3 months. The average price target is $35.22 with a high forecast of $50.00 and a low forecast of $24.00. The average price target represents a 27.06% change from the last price of $27.72.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","26":"$26","51":"$51","13.5":"$13.5","38.5":"$38.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$50.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.22222222222222,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$35.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$24.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,13.5,26,38.5,51],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.94,26.86769230769231,28.795384615384616,30.723076923076924,32.65076923076923,34.57846153846154,36.50615384615385,38.433846153846154,40.36153846153846,42.28923076923077,44.21692307692308,46.144615384615385,48.07230769230769,{"y":50,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.94,25.730940170940173,26.521880341880344,27.312820512820515,28.103760683760683,28.894700854700854,29.685641025641026,30.476581196581197,31.26752136752137,32.058461538461536,32.84940170940171,33.64034188034188,34.431282051282054,{"y":35.22222222222222,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,24.94,24.86769230769231,24.795384615384616,24.723076923076924,24.65076923076923,24.57846153846154,24.506153846153847,24.433846153846154,24.361538461538462,24.28923076923077,24.216923076923077,24.144615384615385,24.072307692307692,{"y":24,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.45,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.22,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.05,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.88,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.07,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.19,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.04,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.81,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.63,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.41,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.94,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$50.00Average Price Target$35.22Lowest Price Target$24.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
JonesTrading Analyst forecast on ANRO
Justin Walsh
JonesTrading
JonesTrading
$44
Buy
58.73%
Upside
Reiterated
05/15/26
JonesTrading Keeps Their Buy Rating on Alto Neuroscience, Inc. (ANRO)
Jefferies Analyst forecast on ANRO
Andrew Tsai
Jefferies
Jefferies
$35
Buy
26.26%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (NYSE: ANRO) and Radnet (NASDAQ: RDNT)
Wedbush Analyst forecast on ANRO
Laura Chico
Wedbush
Wedbush
$21→$24
Hold
-13.42%
Downside
Reiterated
05/14/26
Alto Neuroscience price target raised to $24 from $21 at WedbushAlto Neuroscience price target raised to $24 from $21 at Wedbush
TD Cowen Analyst forecast on ANRO
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/13/26
Ritu Baral Reiterates Buy on Alto Neuroscience, Citing Pivotal ALTO-207 Phase 2b Trial in TRD and Strong Cash Runway Through 2029
William Blair Analyst forecast on ANRO
Myles Minter
William Blair
William Blair
―
Buy
―
Reiterated
05/13/26
Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), BioLife Solutions (BLFS)
BTIG Analyst forecast on ANRO
Thomas Shrader
BTIG
BTIG
$28
Buy
1.01%
Upside
Reiterated
05/13/26
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained
H.C. Wainwright Analyst forecast on ANRO
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
$50
Buy
80.38%
Upside
Reiterated
05/12/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
Bank of America Securities Analyst forecast on ANRO
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$35
Buy
26.26%
Upside
Initiated
05/04/26
Alto Neuroscience initiated with a Buy at BofAAlto Neuroscience initiated with a Buy at BofA
Chardan Capital Analyst forecast on ANRO
Keay Nakae
Chardan Capital
Chardan Capital
$30
Buy
8.23%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (NYSE: ANRO), Arcutis Biotherapeutics (NASDAQ: ARQT) and Valneva (NASDAQ: VALN)
Stifel Nicolaus Analyst forecast on ANRO
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$33
Buy
19.05%
Upside
Reiterated
04/02/26
Stifel Nicolaus Keeps Their Buy Rating on Alto Neuroscience, Inc. (ANRO)
Robert W. Baird Analyst forecast on ANRO
Brian Skorney
Robert W. Baird
Robert W. Baird
$41→$38
Buy
37.09%
Upside
Reiterated
04/02/26
Alto Neuroscience price target lowered to $38 from $41 at BairdAlto Neuroscience price target lowered to $38 from $41 at Baird
Wolfe Research Analyst forecast on ANRO
Rudy Li
Wolfe Research
Wolfe Research
$15
Buy
-45.89%
Downside
Reiterated
10/20/25
Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), Glaukos (GKOS)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
JonesTrading Analyst forecast on ANRO
Justin Walsh
JonesTrading
JonesTrading
$44
Buy
58.73%
Upside
Reiterated
05/15/26
JonesTrading Keeps Their Buy Rating on Alto Neuroscience, Inc. (ANRO)
Jefferies Analyst forecast on ANRO
Andrew Tsai
Jefferies
Jefferies
$35
Buy
26.26%
Upside
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (NYSE: ANRO) and Radnet (NASDAQ: RDNT)
Wedbush Analyst forecast on ANRO
Laura Chico
Wedbush
Wedbush
$21→$24
Hold
-13.42%
Downside
Reiterated
05/14/26
Alto Neuroscience price target raised to $24 from $21 at WedbushAlto Neuroscience price target raised to $24 from $21 at Wedbush
TD Cowen Analyst forecast on ANRO
Ritu Baral
TD Cowen
TD Cowen
―
Buy
―
Reiterated
05/13/26
Ritu Baral Reiterates Buy on Alto Neuroscience, Citing Pivotal ALTO-207 Phase 2b Trial in TRD and Strong Cash Runway Through 2029
William Blair Analyst forecast on ANRO
Myles Minter
William Blair
William Blair
―
Buy
―
Reiterated
05/13/26
Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), BioLife Solutions (BLFS)
BTIG Analyst forecast on ANRO
Thomas Shrader
BTIG
BTIG
$28
Buy
1.01%
Upside
Reiterated
05/13/26
Alto Neuroscience: Buy Rating Reiterated as Lead Asset Advances and Cash Runway Extends; $28 Price Target Maintained
H.C. Wainwright Analyst forecast on ANRO
Patrick Trucchio
H.C. Wainwright
H.C. Wainwright
$50
Buy
80.38%
Upside
Reiterated
05/12/26
Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (NYSE: DNA), Xencor (NASDAQ: XNCR) and Alto Neuroscience, Inc. (NYSE: ANRO)
Bank of America Securities Analyst forecast on ANRO
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$35
Buy
26.26%
Upside
Initiated
05/04/26
Alto Neuroscience initiated with a Buy at BofAAlto Neuroscience initiated with a Buy at BofA
Chardan Capital Analyst forecast on ANRO
Keay Nakae
Chardan Capital
Chardan Capital
$30
Buy
8.23%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (NYSE: ANRO), Arcutis Biotherapeutics (NASDAQ: ARQT) and Valneva (NASDAQ: VALN)
Stifel Nicolaus Analyst forecast on ANRO
Paul Matteis
Stifel Nicolaus
Stifel Nicolaus
$33
Buy
19.05%
Upside
Reiterated
04/02/26
Stifel Nicolaus Keeps Their Buy Rating on Alto Neuroscience, Inc. (ANRO)
Robert W. Baird Analyst forecast on ANRO
Brian Skorney
Robert W. Baird
Robert W. Baird
$41→$38
Buy
37.09%
Upside
Reiterated
04/02/26
Alto Neuroscience price target lowered to $38 from $41 at BairdAlto Neuroscience price target lowered to $38 from $41 at Baird
Wolfe Research Analyst forecast on ANRO
Rudy Li
Wolfe Research
Wolfe Research
$15
Buy
-45.89%
Downside
Reiterated
10/20/25
Analysts' Top Healthcare Picks: Alto Neuroscience, Inc. (ANRO), Glaukos (GKOS)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alto Neuroscience, Inc.

3 Months
xxx
Success Rate
11/12 ratings generated profit
92%
Average Return
+77.79%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 91.67% of your transactions generating a profit, with an average return of +77.79% per trade.
1 Year
Justin WalshJonesTrading
Success Rate
12/12 ratings generated profit
100%
Average Return
+438.69%
Copying Justin Walsh's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +438.69% per trade.
2 Years
xxx
Success Rate
12/12 ratings generated profit
100%
Average Return
+476.29%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +476.29% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ANRO Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
9
4
6
9
10
Buy
2
1
7
13
17
Hold
0
0
1
2
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
5
14
24
32
In the current month, ANRO has received 27 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. ANRO average Analyst price target in the past 3 months is 35.22.
Each month's total comprises the sum of three months' worth of ratings.

ANRO Financial Forecast

ANRO Earnings Forecast

Next quarter’s earnings estimate for ANRO is -$0.68 with a range of -$1.01 to -$0.48. The previous quarter’s EPS was -$0.80. ANRO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ANRO has Performed in-line its overall industry.
Next quarter’s earnings estimate for ANRO is -$0.68 with a range of -$1.01 to -$0.48. The previous quarter’s EPS was -$0.80. ANRO beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ANRO has Performed in-line its overall industry.
No data currently available

ANRO Sales Forecast

Next quarter’s sales forecast for ANRO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ANRO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ANRO has Performed in-line its overall industry.
Next quarter’s sales forecast for ANRO is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ANRO beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ANRO has Performed in-line its overall industry.

ANRO Stock Forecast FAQ

What is ANRO’s average 12-month price target, according to analysts?
Based on analyst ratings, Alto Neuroscience, Inc.’s 12-month average price target is 35.22.
    What is ANRO’s upside potential, based on the analysts’ average price target?
    Alto Neuroscience, Inc. has 27.06% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ANRO a Buy, Sell or Hold?
          Alto Neuroscience, Inc. has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Alto Neuroscience, Inc.’s price target?
            The average price target for Alto Neuroscience, Inc. is 35.22. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $50.00 ,the lowest forecast is $24.00. The average price target represents 27.06% Increase from the current price of $27.72.
              What do analysts say about Alto Neuroscience, Inc.?
              Alto Neuroscience, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of ANRO?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.